ClinicalTrials.gg
Status unknownNCT00465920mCBTUpdated Feb 20, 2009

Development and Pilot Evaluation of Modified Cognitive Behavioural Therapy for Adolescents With Early Onset Psychosis

A Phase 2 interventional study of modified cognitive behavioural therapy (mCBT) in Psychotic Disorders, Schizophrenia and Schizoaffective Disorder, sponsored by University of Cologne. Status unknown at 1 site in Germany. Open to participants aged 14 Years to 18 Years. Per ClinicalTrials.gov, last updated 2009-02-20.

Sponsored by University of Cologne · Phase 2, Interventional, and Treatment

How we know

The sponsor has not verified this record recently (last verified Feb 2009), so the status shown — last known as Recruiting — may be out of date.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 2
Study type
Interventional
Enrollment
42
Allocation
Randomized
Ages
14 Years to 18 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-19

Among 72 studies in Psychotic Disorders with a site in Germany — 19 open to participants now, 21 under way, 4 of them phase 3. Psychotic Disorders · Germany.

Planned enrollment
47th of 65
42 · median 85
Started
2007
with 2 others
Phase 2
3 of 72
none open now
Registered
12th of 72
by date
Lead sponsor
5 of 72
University of Cologne

Among the 72 studies in Psychotic Disorders with a site in Germany, this one is the 47th largest by planned enrollment of the 65 interventional ones that give a count, is one of 3 that started in 2007, is one of 3 in phase 2, and was the 12th registered.

Psychotic Disorders

1,593 studies on the registry are indexed under Psychotic Disorders; 282 are open to participants now.

Browse Psychotic Disorders studies →

Open to participants now

19 of the 72 studies in Psychotic Disorders with a site in Germany are open now. Recruiting first, the newest first:

14 more — sign in →

All 19 open studies →

A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →

Who these studies take

Of the 205 Psychotic Disorders studies recruiting now, 53 (26%) set no upper age limit and 143 (70%) stop at 75 or younger; 50 take children under 18; 41 take healthy volunteers.

This study: 14 Years to 18 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 72 studies in Psychotic Disorders with a site in Germany, or all of them as a file.
02

Study summary

In the last decade cognitive behavioural therapy (CBT) approaches for patients with schizophrenia have been developed, which where especially designed to reduce severity of positive symptoms, readmission rates, treatment non-compliance and disability. Although CBT addresses the key problems of early onset psychoses (EOP)treatment and first evaluations of CBT in adults with schizophrenia are promising, no experience with CBT in adolescents with EOP are available. Therefore the present study is conducted to develop a modified CBT (mCBT) for adolescents with EOP, to explore its acceptance and feasibility and to provide data for a realistic estimation of achievable effect size. Patients are randomized to receive either mCBT+TAU or TAU over a 9 month period. mCBT is an individual outpatient treatment of 20 session and 5 psychoeducational sessions with parents. Follow-ups for two years every 6 months are planned.

03

Conditions studied

  • Psychotic Disorders
  • Schizophrenia
  • Schizoaffective Disorder
  • Delusional Disorder
  • Schizophreniform Disorder

Keywords

  • schizophrenia
  • cognitive behavioural therapy
  • early onset psychosis
  • Psychotic disorders (schizophrenia, schizoaffective disorder, delusional disorder, schizophreniform disorder according to DSM IV) in adolescents
04

Who can participate

Ages eligible
14 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Schizophrenia, schizophreniform or schizoaffective disorder (DSM IV 295.1- .9), delusional disorder (DSM IV 297.1)
  • Score of 4 or more on one of the PANSS-items P1, P3, G9
  • Positive psychotic symptoms for 3 months or more
  • Age between 14 and 18
  • Fluently German speaking

Exclusion criteria

Exclusion Criteria:

  • Diagnosis of delirium, dementia, amnestic or other cognitive disorder, psychiatric disorders due to a somatic factor or related to psychotropic substances according to DSM IV; diseases of the central nervous system
  • Alcohol- or drug dependence according to DSM IV
  • Verbal IQ \< 80
  • Travel time to the study centre of more than 1 hour
05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single
Enrollment
42 participants (estimated)

Interventions

  • Behavioralmodified cognitive behavioural therapy (mCBT)
06

What researchers measure

Primary outcomes

  1. PANSS positive syndrome (sum of items P1-P7), assessed during the treatment phase (9 month) monthly and during the follow-up phase (2 years) every 6 months

Secondary outcomes

  1. additional symptom ratings (PSYRATS)

  2. social functioning (GAF)

  3. illness related events (suicide, suicide attempts, rehospitalisation, severe depressive symptom exacerbation)

  4. quality of life (MSLQ)assessed monthly during the treatment phase (9 months) and every 6 months during the follow-up phase (2 years)

07

Study locations

1 of 1 sites recruiting
  • Department of Psychiatry University Cologne
    Cologne, North Rhine-Westphalia 50937, Germany
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of May 2007 and a completion of Apr 2010. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 25, 2007
First posted
Apr 27, 2007
Start
May 2007
CompletionEst.
Apr 2010
Last update
Feb 20, 2009
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 20, 2009, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00465920
Collaborators
Goethe University, University Hospital Tuebingen
First posted
Apr 27, 2007
Start date
May 2007
Completion
Apr 2010 (estimated)
Last update
Feb 20, 2009

Study contacts

Andreas Bechdolf, PD Dr.
Contact
andreas.bechdolf@uk-koeln.de
+49 221 478 4825
Bettina Pohlmann, Dr.
Contact
bettina.pohlmann@uk-koeln.de
+ 49 221 478 3870
Andreas Bechdolf, PD Dr.
principal investigator · University of Cologne

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2009. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion